Adcock Ingram Holdings (JSE:AIP) Total Liabilities : R2,853 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings Total Liabilities?

Adcock Ingram Holdings's Total Liabilities for the quarter that ended in Dec. 2023 was R2,853 Mil.

Adcock Ingram Holdings's quarterly Total Liabilities increased from Dec. 2022 (R2,559.91 Mil) to Jun. 2023 (R2,874.62 Mil) but then declined from Jun. 2023 (R2,874.62 Mil) to Dec. 2023 (R2,853.16 Mil).

Adcock Ingram Holdings's annual Total Liabilities increased from Jun. 2021 (R2,357.31 Mil) to Jun. 2022 (R2,644.04 Mil) and increased from Jun. 2022 (R2,644.04 Mil) to Jun. 2023 (R2,874.62 Mil).

Adcock Ingram Holdings Total Liabilities Historical Data

The historical data trend for Adcock Ingram Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings Total Liabilities Chart

Adcock Ingram Holdings Annual Data

Trend

Sep13

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Liabilities

Get a 7-Day Free Trial

1,952.60

2,643.25

2,357.31

2,644.04

2,874.62

Adcock Ingram Holdings Semi-Annual Data
	Mar14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															2,550.89	2,644.04	2,559.91	2,874.62	2,853.16

Adcock Ingram Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Adcock Ingram Holdings's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2434.209	+	(279.98	+	147.352
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	13.081)
	=	2,875

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	8262.534	-	5387.912
	=	2,875

Adcock Ingram Holdings's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2444.775	+	(259.528	+	135.636
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	13.216)
	=	2,853

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	8329.023	-	5475.868
	=	2,853

Adcock Ingram Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Adcock Ingram Holdings (JSE:AIP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682

Website

https://www.adcock.com

Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.